A 2nd at-home COVID-19 treatment gets FDA approval.
IronFX is a global leader in online trading, providing exceptional trading conditions and fast execution on a wide range of CFD products.Omicron variant symptoms may be different than previous Covid strains. Learn what you should know about Omicron symptoms and what to look out for.NIAID director Anthony Fauci warned Wednesday that large gatherings this holiday season are unsafe even for fully vaccinated people who've had a COVID-19 booster shot, as the Omicron variant surges across the U.S.
What he's saying: "There are many of these parties that have 30, 40, 50 people in which you do not know the vaccination status of individuals," Fauci said at a briefing. "Those are the kind of functions in the context of Omicron that you do not want to go to."Get market news worthy of yPfizer Inc said on Wednesday the U.S.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
U.S. FDA set to authorize Pfizer, Merck COVID-19 pills this week - Bloomberg NewsThe U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc and Merck as early as Wednesday, Bloomberg News reported on Tuesday, citing people familiar with the matter.
Weiterlesen »
U.S. Adds Merck Pill As 2nd Easy-To-Use Drug Against COVID-19Regulators have authorized an antiviral drug from Merck known as molnupiravir that may help blunt the wave of infections driven by the omicron variant.
Weiterlesen »
FDA authorizes first pill to treat Covid-19The FDA authorizes the first pill to treat Covid-19. Pfizer's Paxlovid is meant to be taken at home before people are sick enough to be hospitalized.
Weiterlesen »
FDA authorizes second antiviral pill to treat Covid-19The US Food and Drug Administration on Thursday authorized Merck's antiviral pill, molnupiravir, to treat Covid-19 'for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate.'
Weiterlesen »
U.S. FDA authorizes Merck's at-home antiviral COVID-19 pillThe U.S. Food and Drug Administration on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving the go-ahead to a similar treatment from Pfizer Inc for high-risk patients above the age of 12.
Weiterlesen »
FDA Authorizes Pfizer Antiviral Pill for COVID-19The FDA was also expected to authorize an antiviral pill from Merck, but as of Wednesday afternoon, only Pfizer's had been authorized for use.
Weiterlesen »